- Home
- FTLF vs CDXS Comparison
FTLF vs CDXS Comparison
Compare FTLF & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTLF | CDXS |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.6M | 141.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | FTLF | CDXS |
|---|---|---|
| Price | $15.83 | $1.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 17.2K | ★ 960.7K |
| Earning Date | 11-13-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $70,561,000.00 | $52,932,000.00 |
| Revenue This Year | $32.74 | $15.64 |
| Revenue Next Year | $50.36 | $5.23 |
| P/E Ratio | $23.18 | ★ N/A |
| Revenue Growth | ★ 12.44 | N/A |
| 52 Week Low | $9.83 | $1.32 |
| 52 Week High | $20.98 | $4.96 |
Technical Indicators
Market Signals| Indicator | FTLF | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 33.46 |
| Support Level | $15.01 | $1.32 |
| Resistance Level | $16.90 | $1.89 |
| Average True Range (ATR) | 0.51 | 0.11 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 49.21 | 4.42 |
Price Performance
Historical ComparisonAbout FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.